These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 36386101)

  • 41. Use of oxybutynin for treating plantar hyperhidrosis.
    Wolosker N; de Campos JR; Kauffman P; Yazbek G; Neves S; Puech-Leao P
    Int J Dermatol; 2013 May; 52(5):620-3. PubMed ID: 23590378
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of topical liposome incorporated clove oil in the treatment of idiopathic palmar hyperhidrosis: Single-blinded placebo-controlled study.
    Ibrahim IM; Abdel Kareem IM; Alghobashy MA
    J Cosmet Dermatol; 2018 Dec; 17(6):1084-1089. PubMed ID: 29285889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Stepwise treatment of primary focal hyperhidrosis with aluminum chloride hexahydrate lotion (20%) and oral glycopyrrolate: a retrospective study from a tertiary care center.
    Patra S; Kaur M; Sharma VK
    Dermatol Ther; 2020 Nov; 33(6):e13914. PubMed ID: 32594603
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Oxybutynin 3% gel for the treatment of primary focal hyperhidrosis in adolescents and young adults.
    Nguyen NV; Gralla J; Abbott J; Bruckner AL
    Pediatr Dermatol; 2018 Mar; 35(2):208-212. PubMed ID: 29334132
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Long-term results of the use of oxybutynin for the treatment of axillary hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Kauffman P; de Campos JR; Puech-Leão P
    Ann Vasc Surg; 2014 Jul; 28(5):1106-12. PubMed ID: 24512855
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A comprehensive approach to the recognition, diagnosis, and severity-based treatment of focal hyperhidrosis: recommendations of the Canadian Hyperhidrosis Advisory Committee.
    Solish N; Bertucci V; Dansereau A; Hong HC; Lynde C; Lupin M; Smith KC; Storwick G;
    Dermatol Surg; 2007 Aug; 33(8):908-23. PubMed ID: 17661933
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of photodynamic therapy for treatment of primary palmar hyperhidrosis.
    Shabaik AHA; Shaheen MA; Soltan MY
    Dermatol Ther; 2021 Jan; 34(1):e14659. PubMed ID: 33301218
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hyperhidrosis: Management Options.
    McConaghy JR; Fosselman D
    Am Fam Physician; 2018 Jun; 97(11):729-734. PubMed ID: 30215934
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality-of-life assessment in patients with hyperhidrosis before and after treatment with botulinum toxin: results of an open-label study.
    Campanati A; Penna L; Guzzo T; Menotta L; Silvestri B; Lagalla G; Gesuita R; Offidani A
    Clin Ther; 2003 Jan; 25(1):298-308. PubMed ID: 12637128
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An open-label tolerability and efficacy study of an aluminum sesquichlorohydrate topical foam in axillary and palmar primary hyperhidrosis.
    Innocenzi D; Ruggero A; Francesconi L; Lacarrubba F; Nardone B; Micali G
    Dermatol Ther; 2008 Jul; 21 Suppl 1():S27-30. PubMed ID: 18727813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Survival study of treatment adherence by patients given oral oxibutynin for hyperhidrosis.
    Millán-Cayetano JF; Del Boz J; García-Montero P; García-Harana C; Rivas Ruiz F; de Troya-Martín M
    J Eur Acad Dermatol Venereol; 2018 Jun; 32(6):1034-1037. PubMed ID: 29220103
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term results of the use of oxybutynin for the treatment of plantar hyperhidrosis.
    Wolosker N; Teivelis MP; Krutman M; de Paula RP; Kauffman P; de Campos JR; Puech-Leão P
    Int J Dermatol; 2015; 54(5):605-11. PubMed ID: 25600990
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of Quality of Life: Functional Assessment of Chronic Illness Therapy after Thoracic Sympathectomy for Palmar Hyperhidrosis.
    Dobosz L; Stefaniak T
    Thorac Cardiovasc Surg; 2019 Aug; 67(5):420-424. PubMed ID: 29672816
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Effect of T4 endoscopic thoracic sympathicotomy on life quality in patients with primary palmar hyperhidrosis].
    Xiao P; Liu A; Liu W
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Oct; 40(10):1126-31. PubMed ID: 26541848
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cost-effectiveness of topical glycopyrronium tosylate for the treatment of primary axillary hyperhidrosis.
    Bloudek LM; Gillard KK; Nguyen VB; Klein SZ
    J Med Econ; 2021; 24(1):29-37. PubMed ID: 33256494
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy and safety of methantheline bromide (Vagantin(®) ) in axillary and palmar hyperhidrosis: results from a multicenter, randomized, placebo-controlled trial.
    Müller C; Berensmeier A; Hamm H; Dirschka T; Reich K; Fischer T; Rzany B
    J Eur Acad Dermatol Venereol; 2013 Oct; 27(10):1278-84. PubMed ID: 23004926
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Therapeutic value of moderate-dose oxybutynin in extensive hyperhidrosis].
    Maillard H; Fenot M; Bara C; Célérier P
    Ann Dermatol Venereol; 2011 Oct; 138(10):652-6. PubMed ID: 21978500
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A Pilot Study of the Safety and Effectiveness of a Novel Device in Subjects With Axillary Hyperhidrosis.
    Kaufman J; Green JB; Cazzaniga A; Canty DJ; Tims E; Waugh J
    Dermatol Surg; 2022 Nov; 48(11):1220-1225. PubMed ID: 36129240
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Thoracoscopic sympathotomy for palmar hyperhidrosis: How young is too young?
    Vasconcelos-Castro S; Soares-Oliveira M; Tuna T; Borges-Dias M
    J Pediatr Surg; 2020 Nov; 55(11):2362-2365. PubMed ID: 31870560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A prospective controlled randomized multicenter study to evaluate the severity of compensatory sweating after one-stage bilateral thoracic sympathectomy versus unilateral thoracic sympathectomy in the dominant side.
    Hamilton NN; Tedde ML; Wolosker N; Aguiar WWS; Ferreira HPDC; Oliveira HA; Lima AMR; Westphal FL; Oliveira MVB; Riuto FO; Pereira STLF; Rezende GC; Valero CEB; Pego-Fernandes PM
    Contemp Clin Trials Commun; 2020 Sep; 19():100618. PubMed ID: 32715152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.